Feeling manipulated: Cytomegalovirus immune manipulation

Virology Journal

Volumn 6, Issue , 2009, Pages

  Miller Kittrell, Mindy ^a   Sparer, Tim E ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; FC RECEPTOR; INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE COFACTOR PROTEIN; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; AMINO ACID SEQUENCE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 8; INNATE IMMUNITY; LIFE CYCLE; NATURAL KILLER CELL; NONHUMAN; PROTEIN BINDING; PROTEIN EXPRESSION; SURVIVAL RATE; T LYMPHOCYTE; VIRUS REPLICATION; VIRUS STRAIN; ANIMAL; CYTOMEGALOVIRUS INFECTION; GENETICS; HUMAN; IMMUNOLOGY; VIROLOGY; VIRUS LATENCY;

CYTOMEGALOVIRUS;

ANIMALS; CYTOKINES; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; HUMANS; IMMUNITY, INNATE; KILLER CELLS, NATURAL; RECEPTORS, CYTOKINE; VIRAL PROTEINS; VIRUS LATENCY; VIRUS REPLICATION;

EID: 60549097787     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/1743-422X-6-4     Document Type: Article

References (333)

1. Viral subversion of the immune system. D Tortorella BE Gewurz MH Furman DJ Schust HL Ploegh, Annu Rev Immunol 2000 18 861 926 10837078
2. The complement system: its importance in the host response to viral infection. RL Hirsch, Microbiol Rev 1982 46 71 85 7045625
3. Neutralization of cytomegalovirus virions: the role of complement. OB Spiller SM Hanna DV Devine F Tufaro, J Infect Dis 1997 176 339 347 9237698
4. Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). GT Spear NS Lurain CJ Parker M Ghassemi GH Payne M Saifuddin, J Immunol 1995 155 4376 4381 7594597
5. Altered expression of host-encoded complement regulators on human cytomegalovirus-infected cells. OB Spiller BP Morgan F Tufaro DV Devine, Eur J Immunol 1996 26 1532 1538 8766557
6. Mechanism of host cell protection from complement in murine cytomegalovirus (CMV) infection: identification of a CMV-responsive element in the CD46 promoter region. M Nomura M Kurita-Taniguchi K Kondo N Inoue M Matsumoto K Yamanishi M Okabe T Seya, Eur J Immunol 2002 32 2954 2964 12355449
7. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function. VM Holers T Kinoshita H Molina, Immunol Today 1992 13 231 236 1378280
8. Cytomegaloviruses. RF Pass, Fields Virology Philadelphia: Lippincott Williams and Williams, David MK, Peter M Howley, 4 2001 2675 2703
9. The development by cytomegalovirus-infected cells of binding affinity for normal human immunoglobulin. D Westmoreland S St Jeor F Rapp, J Immunol 1976 116 1566 1570 178801
10. An IgG-Fc receptor induced in cytomegalovirus-infected human fibroblasts. R Keller R Peitchel JN Goldman M Goldman, J Immunol 1976 116 772 777 176272
11. Appearance of IgG (Fc) receptor(s) on cultured human fibroblasts infected with human cytomegalovirus. AA Rahman M Teschner KK Sethi H Brandis, J Immunol 1976 117 253 258 180179
12. Induction of surface IgG receptors in cytomegalovirus-infected human fibroblasts. J Frey B Einsfelder, Eur J Biochem 1984 138 213 216 6319131
13. Demonstration of immunoglobulin G receptors induced by human cytomegalovirus. T Furukawa E Hornberger S Sakuma SA Plotkin, J Clin Microbiol 1975 2 332 336 171279
14. Characterization of IgG Fc receptors induced by human cytomegalovirus. B Xu T Murayama K Ishida T Furukawa, J Gen Virol 1989 70 Pt 4 893 900 2543765
15. Fc receptor(s) induced by human cytomegalovirus bind differentially with human immunoglobulin G subclasses. T Murayama S Natsuume-Sakai K Shimokawa T Furukawa, J Gen Virol 1986 67 Pt 7 1475 1478 3014057
16. Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. R Thale P Lucin K Schneider M Eggers UH Koszinowski, J Virol 1994 68 7757 7765 7966565
17. IgG Fc receptors. JV Ravetch S Bolland, Annu Rev Immunol 2001 19 275 290 11244038
18. Virus attenuation after deletion of the cytomegalovirus Fc receptor gene is not due to antibody control. I Crnkovic-Mertens M Messerle I Milotic U Szepan N Kucic A Krmpotic S Jonjic UH Koszinowski, J Virol 1998 72 1377 1382 9445038
19. Antibodies are not essential for the resolution of primary cytomegalovirus infection but limit dissemination of recurrent virus. S Jonjic I Pavic B Polic I Crnkovic P Lucin UH Koszinowski, J Exp Med 1994 179 1713 1717 8163949
20. The herpesviral Fc receptor fcr-1 down-regulates the NKG2D ligands MULT-1 and H60. T Lenac M Budt J Arapovic M Hasan A Zimmermann H Simic A Krmpotic M Messerle Z Ruzsics UH Koszinowski H Hengel S Jonjic, J Exp Med 2006 203 1843 1850 16831899
21. Viral interference with B7-1 costimulation: a new role for murine cytomegalovirus fc receptor-1. JD Mintern EJ Klemm M Wagner ME Paquet MD Napier YM Kim UH Koszinowski HL Ploegh, J Immunol 2006 177 8422 8431 17142739
22. Identification and expression of human cytomegalovirus transcription units coding for two distinct Fcgamma receptor homologs. R Atalay A Zimmermann M Wagner E Borst C Benz M Messerle H Hengel, J Virol 2002 76 8596 8608 12163579
23. Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. BN Lilley HL Ploegh RS Tirabassi, J Virol 2001 75 11218 11221 11602761
24. Characterization of domains of herpes simplex virus type 1 glycoprotein E involved in Fc binding activity for immunoglobulin G aggregates. G Dubin S Basu DL Mallory M Basu R Tal-Singer HM Friedman, J Virol 1994 68 2478 2485 7511171
25. In vitro neutralization of HSV-2: inhibition by binding of normal IgG and purified Fc to virion Fc receptor (FcR). KW Dowler RW Veltri, J Med Virol 1984 13 251 259 6327900
26. The human cytomegalovirus Fc receptor gp68 binds the Fc CH2-CH3 interface of immunoglobulin G. ER Sprague H Reinhard EJ Cheung AH Farley RD Trujillo H Hengel PJ Bjorkman, J Virol 2008 82 3490 3499 18216124
27. Engagement of the cellular receptor for glycoprotein B of human cytomegalovirus activates the interferon-responsive pathway. KA Boyle RL Pietropaolo T Compton, Mol Cell Biol 1999 19 3607 3613 10207084
28. Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. H Zhu JP Cong T Shenk, Proc Natl Acad Sci USA 1997 94 13985 13990 9391139
29. Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. KA Simmen J Singh BG Luukkonen M Lopper A Bittner NE Miller MR Jackson T Compton K Fruh, Proc Natl Acad Sci USA 2001 98 7140 7145 11390970
30. Altered cellular mRNA levels in human cytomegalovirus-infected fibroblasts: viral block to the accumulation of antiviral mRNAs. EP Browne B Wing D Coleman T Shenk, J Virol 2001 75 12319 12330 11711622
31. Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. H Zhu JP Cong G Mamtora T Gingeras T Shenk, Proc Natl Acad Sci USA 1998 95 14470 14475 9826724
32. Cytomegalovirus activates interferon immediate-early response gene expression and an interferon regulatory factor 3-containing interferon- stimulated response element-binding complex. L Navarro K Mowen S Rodems B Weaver N Reich D Spector M David, Mol Cell Biol 1998 18 3796 3802 9632763
33. Human cytomegalovirus inhibits IFN-alpha-stimulated antiviral and immunoregulatory responses by blocking multiple levels of IFN-alpha signal transduction. DM Miller Y Zhang BM Rahill WJ Waldman DD Sedmak, J Immunol 1999 162 6107 6113 10229853
34. Cytomegalovirus immune evasion. C Powers V DeFilippis D Malouli K Fruh, Curr Top Microbiol Immunol 2008 325 333 359 18637515
35. Rhesus cytomegalovirus particles prevent activation of interferon regulatory factor 3. V DeFilippis K Fruh, J Virol 2005 79 6419 6431 15858025
36. Pathogen subversion of cell-intrinsic innate immunity. CR Roy ES Mocarski, Nat Immunol 2007 8 1179 1187 17952043
37. Functional role of type I and type II interferons in antiviral defense. U Muller U Steinhoff LF Reis S Hemmi J Pavlovic RM Zinkernagel M Aguet, Science 1994 264 1918 1921 8009221
38. A human cytomegalovirus antagonist of type I IFN-dependent signal transducer and activator of transcription signaling. C Paulus S Krauss M Nevels, Proc Natl Acad Sci USA 2006 103 3840 3845 16497831
39. Binding STAT2 by the acidic domain of human cytomegalovirus IE1 promotes viral growth and is negatively regulated by SUMO. YH Huh YE Kim ET Kim JJ Park MJ Song H Zhu GS Hayward JH Ahn, J Virol 2008 82 10444 10454 18701593
40. Human cytomegalovirus immediate-early 2 gene expression blocks virus-induced beta interferon production. RT Taylor WA Bresnahan, J Virol 2005 79 3873 3877 15731283
41. Human cytomegalovirus IE86 attenuates virus- and tumor necrosis factor alpha-induced NFkappaB-dependent gene expression. RT Taylor WA Bresnahan, J Virol 2006 80 10763 10771 17041226
42. Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response. DA Abate S Watanabe ES Mocarski, J Virol 2004 78 10995 11006 15452220
43. Human cytomegalovirus UL83-coded pp65 virion protein inhibits antiviral gene expression in infected cells. EP Browne T Shenk, Proc Natl Acad Sci USA 2003 100 11439 11444 12972646
44. Human cytomegalovirus immediate-early 2 protein IE86 blocks virus-induced chemokine expression. RT Taylor WA Bresnahan, J Virol 2006 80 920 928 16378994
45. In vivo replication, latency, and immunogenicity of murine cytomegalovirus mutants with deletions in the M83 and M84 genes, the putative homologs of human cytomegalovirus pp65 (UL83). CS Morello LD Cranmer DH Spector, J Virol 1999 73 7678 7693 10438858
46. Murine cytomegalovirus open reading frame M27 plays an important role in growth and virulence in mice. G Abenes M Lee E Haghjoo T Tong X Zhan F Liu, J Virol 2001 75 1697 1707 11160668
47. A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses. A Zimmermann M Trilling M Wagner M Wilborn I Bubic S Jonjic U Koszinowski H Hengel, J Exp Med 2005 201 1543 1553 15883169
48. A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction. S Khan A Zimmermann M Basler M Groettrup H Hengel, J Virol 2004 78 1831 1842 14747547
49. Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis. RS Valchanova M Picard-Maureau M Budt W Brune, J Virol 2006 80 10181 10190 17005695
50. Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins. SJ Child LK Hanson CE Brown DM Janzen AP Geballe, J Virol 2006 80 10173 10180 17005694
51. Double-stranded RNA binding by human cytomegalovirus pTRS1. M Hakki AP Geballe, J Virol 2005 79 7311 7318 15919885
52. Binding and nuclear relocalization of protein kinase R by human cytomegalovirus TRS1. M Hakki EE Marshall KL De Niro AP Geballe, J Virol 2006 80 11817 11826 16987971
53. Evasion of cellular antiviral responses by human cytomegalovirus TRS1 and IRS1. SJ Child M Hakki KL De Niro AP Geballe, J Virol 2004 78 197 205 14671101
54. Cytomegaloviruses. S Edward TS Mocarski Robert F Pass, Fields Virology Philadelphia: Lippincott Williams and Williams, David MK, Peter M Howley, 5 2007 2 2701 2772
55. Modulation of natural killer cells by human cytomegalovirus. GW Wilkinson P Tomasec RJ Stanton M Armstrong V Prod'homme R Aicheler BP McSharry CR Rickards D Cochrane S Llewellyn-Lacey EC Wang CA Griffin AJ Davison, J Clin Virol 2008 41 206 212 18069056
56. The UL16-binding proteins, a novel family of MHC class I-related ligands for NKG2D, activate natural killer cell functions. CL Sutherland NJ Chalupny D Cosman, Immunol Rev 2001 181 185 192 11513139
57. ULBP1, 2, 3: novel MHC class I-related molecules that bind to human cytomegalovirus glycoprotein UL16, activate NK cells. M Kubin L Cassiano J Chalupny W Chin D Cosman W Fanslow J Mullberg AM Rousseau D Ulrich R Armitage, Eur J Immunol 2001 31 1428 1437 11465099
58. ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. D Cosman J Mullberg CL Sutherland W Chin R Armitage W Fanslow M Kubin NJ Chalupny, Immunity 2001 14 123 133 11239445
59. Intracellular retention of the MHC class I-related chain B ligand of NKG2D by the human cytomegalovirus UL16 glycoprotein. J Wu NJ Chalupny TJ Manley SR Riddell D Cosman T Spies, J Immunol 2003 170 4196 4200 12682252
60. Human cytomegalovirus glycoprotein UL16 causes intracellular sequestration of NKG2D ligands, protecting against natural killer cell cytotoxicity. C Dunn NJ Chalupny CL Sutherland S Dosch PV Sivakumar DC Johnson D Cosman, J Exp Med 2003 197 1427 1439 12782710
61. Effects of human cytomegalovirus infection on ligands for the activating NKG2D receptor of NK cells: up-regulation of UL16-binding protein (ULBP)1 and ULBP2 is counteracted by the viral UL16 protein. A Rolle M Mousavi-Jazi M Eriksson J Odeberg C Soderberg-Naucler D Cosman K Karre C Cerboni, J Immunol 2003 171 902 908 12847260
62. The human cytomegalovirus glycoprotein UL16 traffics through the plasma membrane and the nuclear envelope. M Vales-Gomez A Winterhalter P Roda-Navarro A Zimmermann L Boyle H Hengel A Brooks HT Reyburn, Cell Microbiol 2006 8 581 590 16548884
63. Selective intracellular retention of virally induced NKG2D ligands by the human cytomegalovirus UL16 glycoprotein. SA Welte C Sinzger SZ Lutz H Singh-Jasuja KL Sampaio U Eknigk HG Rammensee A Steinle, Eur J Immunol 2003 33 194 203 12594848
64. The human cytomegalovirus protein UL16 mediates increased resistance to natural killer cell cytotoxicity through resistance to cytolytic proteins. J Odeberg H Browne S Metkar CJ Froelich L Branden D Cosman C Soderberg-Naucler, J Virol 2003 77 4539 4545 12663760
65. Host immune system gene targeting by a viral miRNA. N Stern-Ginossar N Elefant A Zimmermann DG Wolf N Saleh M Biton E Horwitz Z Prokocimer M Prichard G Hahn D Goldman-Wohl C Greenfield S Yagel H Hengel Y Altuvia H Margalit O Mandelboim, Science 2007 317 376 381 17641203
66. NK cell activation through the NKG2D ligand MULT-1 is selectively prevented by the glycoprotein encoded by mouse cytomegalovirus gene m145. A Krmpotic M Hasan A Loewendorf T Saulig A Halenius T Lenac B Polic I Bubic A Kriegeskorte E Pernjak-Pugel M Messerle H Hengel DH Busch UH Koszinowski S Jonjic, J Exp Med 2005 201 211 220 15642742
67. The cytomegalovirus m155 gene product subverts natural killer cell antiviral protection by disruption of H60-NKG2D interactions. MB Lodoen G Abenes S Umamoto JP Houchins F Liu LL Lanier, J Exp Med 2004 200 1075 1081 15477345
68. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. M Lodoen K Ogasawara JA Hamerman H Arase JP Houchins ES Mocarski LL Lanier, J Exp Med 2003 197 1245 1253 12756263
69. MCMV glycoprotein gp40 confers virus resistance to CD8+ T cells and NK cells in vivo. A Krmpotic DH Busch I Bubic F Gebhardt H Hengel M Hasan AA Scalzo UH Koszinowski S Jonjic, Nat Immunol 2002 3 529 535 12021778
70. The role of NKG2D signaling in inhibition of cytotoxic T-lymphocyte lysis by the Murine cytomegalovirus immunoevasin m152/gp40. AK Pinto AM Jamieson DH Raulet AB Hill, J Virol 2007 81 12564 12571 17855532
71. Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice. G Abenes K Chan M Lee E Haghjoo J Zhu T Zhou X Zhan F Liu, J Virol 2004 78 6891 6899 15194765
72. Selective down-regulation of the NKG2D ligand H60 by mouse cytomegalovirus m155 glycoprotein. M Hasan A Krmpotic Z Ruzsics I Bubic T Lenac A Halenius A Loewendorf M Messerle H Hengel S Jonjic UH Koszinowski, J Virol 2005 79 2920 2930 15709011
73. Murine cytomegalovirus with a deletion of genes spanning HindIII-J and -I displays altered cell and tissue tropism. VJ Cavanaugh RM Stenberg TL Staley HWt Virgin MR MacDonald S Paetzold HE Farrell WD Rawlinson AE Campbell, J Virol 1996 70 1365 1374 8627652
74. Analysis of the complete DNA sequence of murine cytomegalovirus. WD Rawlinson HE Farrell BG Barrell, J Virol 1996 70 8833 8849 8971012
75. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. H Arase ES Mocarski AE Campbell AB Hill LL Lanier, Science 2002 296 1323 1326 11950999
76. Characterization of Murine Cytomegalovirus m157 from Infected Cells and Identification of Critical Residues Mediating Recognition by the NK Cell Receptor Ly49H. AH Davis NV Guseva BL Ball JW Heusel, J Immunol 2008 181 265 275 18566392
77. Expression of m157, a murine cytomegalovirus-encoded putative major histocompatibility class I (MHC-I)-like protein, is independent of viral regulation of host MHC-I. SK Tripathy HR Smith EA Holroyd JT Pingel WM Yokoyama, J Virol 2006 80 545 550 16352579
78. Critical residues at the Ly49 natural killer receptor's homodimer interface determine functional recognition of m157, a mouse cytomegalovirus MHC class I-like protein. A Kielczewska HS Kim LL Lanier N Dimasi SM Vidal, J Immunol 2007 178 369 377 17182575
79. Recognition of a virus-encoded ligand by a natural killer cell activation receptor. HR Smith JW Heusel IK Mehta S Kim BG Dorner OV Naidenko K Iizuka H Furukawa DL Beckman JT Pingel AA Scalzo DH Fremont WM Yokoyama, Proc Natl Acad Sci USA 2002 99 8826 8831 12060703
80. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. BG Dorner HR Smith AR French S Kim J Poursine-Laurent DL Beckman JT Pingel RA Kroczek WM Yokoyama, J Immunol 2004 172 3119 3131 14978118
81. Structural elucidation of the m157 mouse cytomegalovirus ligand for Ly49 natural killer cell receptors. EJ Adams ZS Juo RT Venook MJ Boulanger H Arase LL Lanier KC Garcia, Proc Natl Acad Sci USA 2007 104 10128 10133 17537914
82. Gain of virulence caused by loss of a gene in murine cytomegalovirus. I Bubic M Wagner A Krmpotic T Saulig S Kim WM Yokoyama S Jonjic UH Koszinowski, J Virol 2004 78 7536 7544 15220428
83. Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. KA Daniels G Devora WC Lai CL O'Donnell M Bennett RM Welsh, J Exp Med 2001 194 29 44 11435470
84. Ly49h-deficient C57BL/6 mice: a new mouse cytomegalovirus-susceptible model remains resistant to unrelated pathogens controlled by the NK gene complex. N Fodil-Cornu SH Lee S Belanger AP Makrigiannis CA Biron RM Buller SM Vidal, J Immunol 2008 181 6394 6405 18941230
85. Murine cytomegalovirus m157 mutation and variation leads to immune evasion of natural killer cells. V Voigt CA Forbes JN Tonkin MA Degli-Esposti HR Smith WM Yokoyama AA Scalzo, Proc Natl Acad Sci USA 2003 100 13483 13488 14597723
86. Transcriptional analysis of the murine cytomegalovirus HindIII-I region: identification of a novel immediate-early gene region. LK Hanson BL Dalton Z Karabekian HE Farrell WD Rawlinson RM Stenberg AE Campbell, Virology 1999 260 156 164 10405367
87. Characterization of a murine cytomegalovirus class I major histocompatibility complex (MHC) homolog: comparison to MHC molecules and to the human cytomegalovirus MHC homolog. TL Chapman PJ Bjorkman, J Virol 1998 72 460 466 9420246
88. m144, a murine cytomegalovirus (MCMV)-encoded major histocompatibility complex class I homologue, confers tumor resistance to natural killer cell-mediated rejection. E Cretney MA Degli-Esposti EH Densley HE Farrell NJ Davis-Poynter MJ Smyth, J Exp Med 1999 190 435 444 10430631
89. Inhibition of natural killer cells by a cytomegalovirus MHC class I homologue in vivo. HE Farrell H Vally DM Lynch P Fleming GR Shellam AA Scalzo NJ Davis-Poynter, Nature 1997 386 510 514 9087412
90. Crystal structure of the murine cytomegalovirus MHC-I homolog m144. K Natarajan A Hicks J Mans H Robinson R Guan RA Mariuzza DH Margulies, J Mol Biol 2006 358 157 171 16500675
91. The r144 major histocompatibility complex class I-like gene of rat cytomegalovirus is dispensable for both acute and long-term infection in the immunocompromised host. PS Beisser JS Kloover GE Grauls MJ Blok CA Bruggeman C Vink, J Virol 2000 74 1045 1050 10623772
92. A rat cytomegalovirus strain with a disruption of the r144 MHC class I-like gene is attenuated in the acute phase of infection in neonatal rats. JS Kloover GE Grauls MJ Blok C Vink CA Bruggeman, Arch Virol 2002 147 813 824 12038690
93. Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. S Beck BG Barrell, Nature 1988 331 269 272 2827039
94. Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. CS Wagner HG Ljunggren A Achour, J Immunol 2008 180 19 24 18096997
95. A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. H Browne G Smith S Beck T Minson, Nature 1990 347 770 772 2172831
96. The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. ML Fahnestock JL Johnson RM Feldman JM Neveu WS Lane PJ Bjorkman, Immunity 1995 3 583 590 7584148
97. A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. D Cosman N Fanger L Borges M Kubin W Chin L Peterson ML Hsu, Immunity 1997 7 273 282 9285411
98. Structure of UL18, a peptide-binding viral MHC mimic, bound to a host inhibitory receptor. Z Yang PJ Bjorkman, Proc Natl Acad Sci USA 2008 105 10095 10100 18632577
99. Dissecting the structural determinants of the interaction between the human cytomegalovirus UL18 protein and the CD85j immune receptor. M Occhino F Ghiotto S Soro M Mortarino S Bosi M Maffei S Bruno M Nardini M Figini A Tramontano E Ciccone, J Immunol 2008 180 957 968 18178836
100. The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. TL Chapman AP Heikeman PJ Bjorkman, Immunity 1999 11 603 613 10591185
101. Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. CC Leong TL Chapman PJ Bjorkman D Formankova ES Mocarski JH Phillips LL Lanier, J Exp Med 1998 187 1681 1687 9584146
102. The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. HT Reyburn O Mandelboim M Vales-Gomez DM Davis L Pazmany JL Strominger, Nature 1997 386 514 517 9087413
103. The human cytomegalovirus MHC class I homolog UL18 inhibits LIR-1+ but activates LIR-1-NK cells. V Prod'homme C Griffin RJ Aicheler EC Wang BP McSharry CR Rickards RJ Stanton LK Borysiewicz M Lopez-Botet GW Wilkinson P Tomasec, J Immunol 2007 178 4473 4481 17372005
104. Increased expression of leukocyte Ig-like receptor-1 and activating role of UL18 in the response to cytomegalovirus infection. CS Wagner GC Riise T Bergstrom K Karre E Carbone L Berg, J Immunol 2007 178 3536 3543 17339449
105. Human cytomegalovirus UL18 alleviated human NK-mediated swine endothelial cell lysis. JS Kim SE Choi IH Yun JY Kim C Ahn SJ Kim J Ha ES Hwang CY Cha S Miyagawa CG Park, Biochem Biophys Res Commun 2004 315 144 150 15013438
106. Specific recognition of the viral protein UL18 by CD85j/LIR-1/ILT2 on CD8+ T cells mediates the non-MHC-restricted lysis of human cytomegalovirus- infected cells. D Saverino F Ghiotto A Merlo S Bruno L Battini M Occhino M Maffei C Tenca S Pileri L Baldi M Fabbi A Bachi A De Santanna CE Grossi E Ciccone, J Immunol 2004 172 5629 5637 15100307
107. Variability of UL18, UL40, UL111a and US3 immunomodulatory genes among human cytomegalovirus clinical isolates from renal transplant recipients. I Garrigue MF Corte N Magnin L Couzi S Capdepont C Rio P Merville J Dechanet-Merville H Fleury ME Lafon, J Clin Virol 2007 40 120 128 17827058
108. Spontaneous mutations in the human CMV HLA class I homologue UL18 affect its binding to the inhibitory receptor LIR-1/ILT2/CD85j. C Cerboni A Achour A Warnmark M Mousavi-Jazi T Sandalova ML Hsu D Cosman K Karre E Carbone, Eur J Immunol 2006 36 732 741 16479538
109. Human cytomegalovirus (HCMV)-infected endothelial cells and macrophages are less susceptible to natural killer lysis independent of the downregulation of classical HLA class I molecules or expression of the HCMV class I homologue, UL18. J Odeberg C Cerboni H Browne K Karre E Moller E Carbone C Soderberg-Naucler, Scand J Immunol 2002 55 149 161 11896931
110. Human cytomegalovirus-derived protein UL18 alters the phenotype and function of monocyte-derived dendritic cells. CS Wagner L Walther-Jallow E Buentke HG Ljunggren A Achour BJ Chambers, J Leukoc Biol 2008 83 56 63 17898320
111. The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products. B Park H Oh S Lee Y Song J Shin YC Sung SY Hwang K Ahn, J Immunol 2002 168 3464 3469 11907106
112. Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses. Y Kim B Park S Cho J Shin K Cho Y Jun K Ahn, PLoS Pathog 2008 4 e1000123 18688275
113. Transcription of the human cytomegalovirus natural killer decoy gene, UL18, in vitro and in vivo. AF Hassan-Walker AV Cope PD Griffiths VC Emery, J Gen Virol 1998 79 Pt 9 2113 2116 9747719
114. The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome. AJ Davison A Dolan P Akter C Addison DJ Dargan DJ Alcendor DJ McGeoch GS Hayward, J Gen Virol 2003 84 17 28 12533697
115. Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysis. MR Wills O Ashiru MB Reeves G Okecha J Trowsdale P Tomasec GW Wilkinson J Sinclair JG Sissons, J Immunol 2005 175 7457 7465 16301653
116. Down-regulation of the NKG2D ligand MICA by the human cytomegalovirus glycoprotein UL142. NJ Chalupny A Rein-Weston S Dosch D Cosman, Biochem Biophys Res Commun 2006 346 175 181 16750166
117. UL40-mediated NK evasion during productive infection with human cytomegalovirus. EC Wang B McSharry C Retiere P Tomasec S Williams LK Borysiewicz VM Braud GW Wilkinson, Proc Natl Acad Sci USA 2002 99 7570 7575 12032324
118. Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. P Tomasec VM Braud C Rickards MB Powell BP McSharry S Gadola V Cerundolo LK Borysiewicz AJ McMichael GW Wilkinson, Science 2000 287 1031 10669413
119. Cutting edge: the human cytomegalovirus UL40 gene product contains a ligand for HLA-E and prevents NK cell-mediated lysis. M Ulbrecht S Martinozzi M Grzeschik H Hengel JW Ellwart M Pla EH Weiss, J Immunol 2000 164 5019 5022 10799855
120. Synergistic effect of IFN-gamma and human cytomegalovirus protein UL40 in the HLA-E-dependent protection from NK cell-mediated cytotoxicity. C Cerboni M Mousavi-Jazi H Wakiguchi E Carbone K Karre K Soderstrom, Eur J Immunol 2001 31 2926 2935 11592068
121. The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. PJ Lehner JT Karttunen GW Wilkinson P Cresswell, Proc Natl Acad Sci USA 1997 94 6904 6909 9192664
122. NK cell activity during human cytomegalovirus infection is dominated by US2-11-mediated HLA class I down-regulation. CS Falk M Mach DJ Schendel EH Weiss I Hilgert G Hahn, J Immunol 2002 169 3257 3266 12218145
123. HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes. G Pietra C Romagnani P Mazzarino M Falco E Millo A Moretta L Moretta MC Mingari, Proc Natl Acad Sci USA 2003 100 10896 10901 12960383
124. Identification of effector-memory CMV-specific T lymphocytes that kill CMV-infected target cells in an HLA-E-restricted fashion. P Mazzarino G Pietra P Vacca M Falco D Colau P Coulie L Moretta MC Mingari, Eur J Immunol 2005 35 3240 3247 16224817
125. Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. TI Arnon H Achdout O Levi G Markel N Saleh G Katz R Gazit T Gonen-Gross J Hanna E Nahari A Porgador A Honigman B Plachter D Mevorach DG Wolf O Mandelboim, Nat Immunol 2005 6 515 523 15821739
126. Downregulation of natural killer cell-activating ligand CD155 by human cytomegalovirus UL141. P Tomasec EC Wang AJ Davison B Vojtesek M Armstrong C Griffin BP McSharry RJ Morris S Llewellyn-Lacey C Rickards A Nomoto C Sinzger GW Wilkinson, Nat Immunol 2005 6 181 188 15640804
127. Interleukin-10 and the interleukin-10 receptor. KW Moore R de Waal Malefyt RL Coffman A O'Garra, Annu Rev Immunol 2001 19 683 765 11244051
128. Hijacking and exploitation of IL-10 by intracellular pathogens. S Redpath P Ghazal NR Gascoigne, Trends Microbiol 2001 9 86 92 11173248
129. Human cytomegalovirus harbors its own unique IL-10 homolog (cmvIL-10). SV Kotenko S Saccani LS Izotova OV Mirochnitchenko S Pestka, Proc Natl Acad Sci USA 2000 97 1695 1700 10677520
130. Potent immunosuppressive activities of cytomegalovirus-encoded interleukin-10. JV Spencer KM Lockridge PA Barry G Lin M Tsang ME Penfold TJ Schall, J Virol 2002 76 1285 1292 11773404
131. Shaping phenotype, function, and survival of dendritic cells by cytomegalovirus-encoded IL-10. MJ Raftery D Wieland S Gronewald AA Kraus T Giese G Schonrich, J Immunol 2004 173 3383 3391 15322202
132. Human cytomegalovirus-encoded interleukin-10 homolog inhibits maturation of dendritic cells and alters their functionality. WL Chang N Baumgarth D Yu PA Barry, J Virol 2004 78 8720 8731 15280480
133. Crystal structure of human cytomegalovirus IL-10 bound to soluble human IL-10R1. BC Jones NJ Logsdon K Josephson J Cook PA Barry MR Walter, Proc Natl Acad Sci USA 2002 99 9404 9409 12093920
134. The cytomegalovirus homolog of interleukin-10 requires phosphatidylinositol 3-kinase activity for inhibition of cytokine synthesis in monocytes. JV Spencer, J Virol 2007 81 2083 2086 17121792
135. Stimulation of B lymphocytes by cmvIL-10 but not LAcmvIL-10. JV Spencer J Cadaoas PR Castillo V Saini B Slobedman, Virology 2008 374 164 169 18222515
136. Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. T Yamamoto-Tabata S McDonagh HT Chang S Fisher L Pereira, J Virol 2004 78 2831 2840 14990702
137. A novel viral transcript with homology to human interleukin-10 is expressed during latent human cytomegalovirus infection. C Jenkins A Abendroth B Slobedman, J Virol 2004 78 1440 1447 14722299
138. Expression of a human cytomegalovirus latency-associated homolog of interleukin-10 during the productive phase of infection. C Jenkins W Garcia A Abendroth B Slobedman, Virology 2008 370 285 294 17942134
139. Immunomodulatory properties of a viral homolog of human interleukin-10 expressed by human cytomegalovirus during the latent phase of infection. C Jenkins W Garcia MJ Godwin JV Spencer JL Stern A Abendroth B Slobedman, J Virol 2008 82 3736 3750 18216121
140. Primate cytomegaloviruses encode and express an IL-10-like protein. KM Lockridge SS Zhou RH Kravitz JL Johnson ET Sawai EL Blewett PA Barry, Virology 2000 268 272 280 10704336
141. Murine cytomegalovirus infection down-regulates MHC class II expression on macrophages by induction of IL-10. S Redpath A Angulo NR Gascoigne P Ghazal, J Immunol 1999 162 6701 6707 10352288
142. Vigorous innate and virus-specific cytotoxic T-lymphocyte responses to murine cytomegalovirus in the submaxillary salivary gland. VJ Cavanaugh Y Deng MP Birkenbach JS Slater AE Campbell, J Virol 2003 77 1703 1717 12525604
143. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. CA Benedict KD Butrovich NS Lurain J Corbeil I Rooney P Schneider J Tschopp CF Ware, J Immunol 1999 162 6967 6970 10358135
144. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. NS Lurain KS Kapell DD Huang JA Short J Paintsil E Winkfield CA Benedict CF Ware JW Bremer, J Virol 1999 73 10040 10050 10559318
145. The UL144 gene product of human cytomegalovirus activates NFkappaB via a TRAF6-dependent mechanism. E Poole CA King JH Sinclair A Alcami, EMBO J 2006 25 4390 4399 16932746
146. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. TC Cheung IR Humphreys KG Potter PS Norris HM Shumway BR Tran G Patterson R Jean-Jacques M Yoon PG Spear KM Murphy NS Lurain CA Benedict CF Ware, Proc Natl Acad Sci USA 2005 102 13218 13223 16131544
147. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. JR Sedy M Gavrieli KG Potter MA Hurchla RC Lindsley K Hildner S Scheu K Pfeffer CF Ware TL Murphy KM Murphy, Nat Immunol 2005 6 90 98 15568026
148. NF-kappaB-mediated activation of the chemokine CCL22 by the product of the human cytomegalovirus gene UL144 escapes regulation by viral IE86. E Poole E Atkins T Nakayama O Yoshie I Groves A Alcami J Sinclair, J Virol 2008 82 4250 4256 18287226
149. Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection. R Arav-Boger CA Battaglia T Lazzarotto L Gabrielli JC Zong GS Hayward M Diener-West MP Landini, J Infect Dis 2006 194 464 473 16845629
150. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. R Arav-Boger RE Willoughby RF Pass JC Zong WJ Jang D Alcendor GS Hayward, J Infect Dis 2002 186 1057 1064 12355354
151. Human cytomegalovirus a sequence and UL144 variability in strains from infected children. JF Bale Jr SJ Petheram M Robertson JR Murph G Demmler, J Med Virol 2001 65 90 96 11505449
152. Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children. J Heo S Petheram G Demmler JR Murph SP Adler J Bale TE Sparer, Virology 2008 18556037
153. Genetic polymorphism of UL144 open reading frame of human cytomegalovirus DNA detected in colon samples from infants with Hirschsprung's disease. ZQ Mao Y Huang M Sun Q Ruan Y Qi R He YJ Huang YP Ma YH Ji ZR Sun H Gao, World J Gastroenterol 2007 13 4350 4354 17708610
154. Human cytomegalovirus UL144 gene polymorphisms in congenital infections. O Picone JM Costa ML Chaix Y Ville C Rouzioux M Leruez-Ville, J Clin Microbiol 2005 43 25 29 15634946
155. Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children. H Yan S Koyano Y Inami Y Yamamoto T Suzutani M Mizuguchi H Ushijima I Kurane N Inoue, Arch Virol 2008 153 667 674 18273679
156. Late expression of a beta chemokine homolog by murine cytomegalovirus. MR MacDonald XY Li HWt Virgin, J Virol 1997 71 1671 1678 8995698
157. Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemokine of novel structure. MR MacDonald MW Burney SB Resnick HI Virgin, J Virol 1999 73 3682 3691 10196260
158. Genes of murine cytomegalovirus exist as a number of distinct genotypes. LM Smith GR Shellam AJ Redwood, Virology 2006 352 450 465 16781754
159. Cytomegalovirus-encoded beta chemokine promotes monocyte-associated viremia in the host. N Saederup YC Lin DJ Dairaghi TJ Schall ES Mocarski, Proc Natl Acad Sci USA 1999 96 10881 10886 10485920
160. Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. N Saederup SA Aguirre TE Sparer DM Bouley ES Mocarski, J Virol 2001 75 9966 9976 11559829
161. The murine cytomegalovirus chemokine homolog, m131/129, is a determinant of viral pathogenicity. P Fleming N Davis-Poynter M Degli-Esposti E Densley J Papadimitriou G Shellam H Farrell, J Virol 1999 73 6800 6809 10400778
162. Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. S Noda SA Aguirre A Bitmansour JM Brown TE Sparer J Huang ES Mocarski, Blood 2006 107 30 38 16046529
163. Complete DNA sequence of the rat cytomegalovirus genome. C Vink E Beuken CA Bruggeman, J Virol 2000 74 7656 7665 10906222
164. The r131 gene of rat cytomegalovirus encodes a proinflammatory CC chemokine homolog which is essential for the production of infectious virus in the salivary glands. SJ Kaptein KW van Cleef YK Gruijthuijsen EV Beuken L van Buggenhout PS Beisser FR Stassen CA Bruggeman C Vink, Virus Genes 2004 29 43 61 15215683
165. A macrophage inflammatory protein homolog encoded by guinea pig cytomegalovirus signals via CC chemokine receptor 1. M Penfold Z Miao Y Wang S Haggerty MR Schleiss, Virology 2003 316 202 212 14644603
166. A novel CC-chemokine homolog encoded by guinea pig cytomegalovirus. SM Haggerty MR Schleiss, Virus Genes 2002 25 271 279 12881638
167. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. TA Cha E Tom GW Kemble GM Duke ES Mocarski RR Spaete, J Virol 1996 70 78 83 8523595
168. Cytomegalovirus encodes a potent alpha chemokine. ME Penfold DJ Dairaghi GM Duke N Saederup ES Mocarski GW Kemble TJ Schall, Proc Natl Acad Sci USA 1999 96 9839 9844 10449781
169. Human cytomegalovirus UL131-128 genes are indispensable for virus growth in endothelial cells and virus transfer to leukocytes. G Hahn MG Revello M Patrone E Percivalle G Campanini A Sarasini M Wagner A Gallina G Milanesi U Koszinowski F Baldanti G Gerna, J Virol 2004 78 10023 10033 15331735
170. Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1(CCMV). M Miller-Kittrell J Sai M Penfold A Richmond TE Sparer, Virology 2007 364 454 465 17433398
171. Loss of linkage disequilibrium and accelerated protein divergence in duplicated cytomegalovirus chemokine genes. R Arav-Boger JC Zong CB Foster, Virus Genes 2005 31 65 72 15965610
172. Sequence variability of the alpha-chemokine UL146 from clinical strains of human cytomegalovirus. AF Hassan-Walker S Okwuadi L Lee PD Griffiths VC Emery, J Med Virol 2004 74 573 579 15484281
173. Genotypic analysis of two hypervariable human cytomegalovirus genes. AJ Bradley IJ Kovacs D Gatherer DJ Dargan KR Alkharsah PK Chan WF Carman M Dedicoat VC Emery CC Geddes G Gerna B Ben-Ismaeil S Kaye A McGregor PA Moss R Pusztai WD Rawlinson GM Scott GW Wilkinson TF Schulz AJ Davison, J Med Virol 2008 80 1615 1623 18649324
174. Two novel spliced genes in human cytomegalovirus. P Akter C Cunningham BP McSharry A Dolan C Addison DJ Dargan AF Hassan-Walker VC Emery PD Griffiths GW Wilkinson AJ Davison, J Gen Virol 2003 84 1117 1122 12692276
175. Human cytomegalovirus virion protein complex required for epithelial and endothelial cell tropism. D Wang T Shenk, Proc Natl Acad Sci USA 2005 102 18153 18158 16319222
176. Human cytomegalovirus UL131 open reading frame is required for epithelial cell tropism. D Wang T Shenk, J Virol 2005 79 10330 10338 16051825
177. Human cytomegalovirus encodes three G protein-coupled receptor homologues. MS Chee SC Satchwell E Preddie KM Weston BG Barrell, Nature 1990 344 774 777 2158627
178. Chemokines and chemokine receptors encoded by cytomegaloviruses. PS Beisser H Lavreysen CA Bruggeman C Vink, Curr Top Microbiol Immunol 2008 325 221 242 18637509
179. The molecular biology of leukocyte chemoattractant receptors. PM Murphy, Annu Rev Immunol 1994 12 593 633 8011292
180. Cytomegalovirus-encoded homologs of G protein-coupled receptors and chemokines. KW van Cleef MJ Smit CA Bruggeman C Vink, J Clin Virol 2006 35 343 348 16406796
181. Human cytomegalovirus open reading frame US28 encodes a functional beta chemokine receptor. JL Gao PM Murphy, J Biol Chem 1994 269 28539 28542 7961796
182. The cytomegalovirus US28 protein binds multiple CC chemokines with high affinity. DE Kuhn CJ Beall PE Kolattukudy, Biochem Biophys Res Commun 1995 211 325 330 7540006
183. Selective recognition of the membrane-bound CX3C chemokine, fractalkine, by the human cytomegalovirus-encoded broad-spectrum receptor US28. TN Kledal MM Rosenkilde TW Schwartz, FEBS Lett 1998 441 209 214 9883886
184. Modulation of RANTES production by human cytomegalovirus infection of fibroblasts. S Michelson P Dal Monte D Zipeto B Bodaghi L Laurent E Oberlin F Arenzana-Seisdedos JL Virelizier MP Landini, J Virol 1997 71 6495 6500 9261368
185. Chemokine sequestration by viral chemoreceptors as a novel viral escape strategy: withdrawal of chemokines from the environment of cytomegalovirus- infected cells. B Bodaghi TR Jones D Zipeto C Vita L Sun L Laurent F Arenzana-Seisdedos JL Virelizier S Michelson, J Exp Med 1998 188 855 866 9730887
186. Functional analysis of the human cytomegalovirus US28 gene by insertion mutagenesis with the green fluorescent protein gene. J Vieira TJ Schall L Corey AP Geballe, J Virol 1998 72 8158 8165 9733857
187. The expression of the cytomegalovirus chemokine receptor homolog US28 sequesters biologically active CC chemokines and alters IL-8 production. JR Randolph-Habecker B Rahill B Torok-Storb J Vieira PE Kolattukudy BH Rovin DD Sedmak, Cytokine 2002 19 37 46 12200112
188. The human cytomegalovirus US28 protein is located in endocytic vesicles and undergoes constitutive endocytosis and recycling. A Fraile-Ramos TN Kledal A Pelchen-Matthews K Bowers TW Schwartz M Marsh, Mol Biol Cell 2001 12 1737 1749 11408581
189. The chemokine receptor homologue encoded by US27 of human cytomegalovirus is heavily glycosylated and is present in infected human foreskin fibroblasts and enveloped virus particles. BJ Margulies W Gibson, Virus Res 2007 123 57 71 16963142
190. Intracellular signaling by the chemokine receptor US28 during human cytomegalovirus infection. MA Billstrom GL Johnson NJ Avdi GS Worthen, J Virol 1998 72 5535 5544 9621010
191. Constitutive signaling of the human cytomegalovirus-encoded chemokine receptor US28. P Casarosa RA Bakker D Verzijl M Navis H Timmerman R Leurs MJ Smit, J Biol Chem 2001 276 1133 1137 11050102
192. Characterization of G-protein alpha subunits in the Gq class: expression in murine tissues and in stromal and hematopoietic cell lines. TM Wilkie PA Scherle MP Strathmann VZ Slepak MI Simon, Proc Natl Acad Sci USA 1991 88 10049 10053 1946421
193. The human cytomegalovirus chemokine receptor US28 mediates vascular smooth muscle cell migration. DN Streblow C Soderberg-Naucler J Vieira P Smith E Wakabayashi F Ruchti K Mattison Y Altschuler JA Nelson, Cell 1999 99 511 520 10589679
194. The HCMV chemokine receptor US28 is a potential target in vascular disease. DN Streblow SL Orloff JA Nelson, Curr Drug Targets Infect Disord 2001 1 151 158 12455411
195. Similar activation of signal transduction pathways by the herpesvirus-encoded chemokine receptors US28 and ORF74. KA McLean PJ Holst L Martini TW Schwartz MM Rosenkilde, Virology 2004 325 241 251 15246264
196. Murine cytomegalovirus (CMV) M33 and human CMV US28 receptors exhibit similar constitutive signaling activities. M Waldhoer TN Kledal H Farrell TW Schwartz, J Virol 2002 76 8161 8168 12134021
197. Functional analysis of human cytomegalovirus pUS28 mutants in infected cells. MP Stropes WE Miller, J Gen Virol 2008 89 97 105 18089733
198. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. WE Miller DA Houtz CD Nelson PE Kolattukudy RJ Lefkowitz, J Biol Chem 2003 278 21663 21671 12668664
199. Human cytomegalovirus-encoded chemokine receptor US28 promotes tumorigenesis. D Maussang D Verzijl M van Walsum R Leurs J Holl O Pleskoff D Michel GA van Dongen MJ Smit, Proc Natl Acad Sci USA 2006 103 13068 13073 16924106
200. Association between prior cytomegalovirus infection and the risk of restenosis after coronary atherectomy. YF Zhou MB Leon MA Waclawiw JJ Popma ZX Yu T Finkel SE Epstein, N Engl J Med 1996 335 624 630 8687516
201. Cytomegalovirus and atherosclerosis. JL Melnick E Adam ME Debakey, Eur Heart J 1993 14 Suppl K 30 38 8131785
202. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. L Harkins AL Volk M Samanta I Mikolaenko WJ Britt KI Bland CS Cobbs, Lancet 2002 360 1557 1563 12443594
203. Human cytomegalovirus infection and expression in human malignant glioma. CS Cobbs L Harkins M Samanta GY Gillespie S Bharara PH King LB Nabors CG Cobbs WJ Britt, Cancer Res 2002 62 3347 3350 12067971
204. Mouse cytomegalovirus M33 is necessary and sufficient in virus-induced vascular smooth muscle cell migration. RM Melnychuk P Smith CN Kreklywich F Ruchti J Vomaske L Hall L Loh JA Nelson SL Orloff DN Streblow, J Virol 2005 79 10788 10795 16051870
205. The rat cytomegalovirus R33-encoded G protein-coupled receptor signals in a constitutive fashion. YK Gruijthuijsen P Casarosa SJ Kaptein JL Broers R Leurs CA Bruggeman MJ Smit C Vink, J Virol 2002 76 1328 1338 11773407
206. Constitutive signaling of the human cytomegalovirus-encoded receptor UL33 differs from that of its rat cytomegalovirus homolog R33 by promiscuous activation of G proteins of the Gq, Gi, and Gs classes. P Casarosa YK Gruijthuijsen D Michel PS Beisser J Holl CP Fitzsimons D Verzijl CA Bruggeman T Mertens R Leurs C Vink MJ Smit, J Biol Chem 2003 278 50010 50023 14522997
207. G protein-coupled receptor (GPCR) kinase 2 regulates agonist-independent Gq/11 signaling from the mouse cytomegalovirus GPCR M33. JD Sherrill WE Miller, J Biol Chem 2006 281 39796 39805 17088245
208. Identification of the human cytomegalovirus G protein-coupled receptor homologue encoded by UL33 in infected cells and enveloped virus particles. BJ Margulies H Browne W Gibson, Virology 1996 225 111 125 8918538
209. Identification and characterization of a G protein-coupled receptor homolog encoded by murine cytomegalovirus. NJ Davis-Poynter DM Lynch H Vally GR Shellam WD Rawlinson BG Barrell HE Farrell, J Virol 1997 71 1521 1529 8995678
210. The R33 G protein-coupled receptor gene of rat cytomegalovirus plays an essential role in the pathogenesis of viral infection. PS Beisser C Vink JG Van Dam G Grauls SJ Vanherle CA Bruggeman, J Virol 1998 72 2352 2363 9499096
211. Functional analysis of the murine cytomegalovirus chemokine receptor homologue M33: ablation of constitutive signaling is associated with an attenuated phenotype in vivo. R Case E Sharp T Benned-Jensen MM Rosenkilde N Davis-Poynter HE Farrell, J Virol 2008 82 1884 1898 18057236
212. Rat cytomegalovirus-accelerated transplant vascular sclerosis is reduced with mutation of the chemokine-receptor R33. DN Streblow CN Kreklywich P Smith JL Soule C Meyer M Yin P Beisser C Vink JA Nelson SL Orloff, Am J Transplant 2005 5 436 442 15707397
213. Murine cytomegalovirus M78 protein, a G protein-coupled receptor homologue, is a constituent of the virion and facilitates accumulation of immediate-early viral mRNA. SA Oliveira TE Shenk, Proc Natl Acad Sci USA 2001 98 3237 3242 11248062
214. Deletion of the R78 G protein-coupled receptor gene from rat cytomegalovirus results in an attenuated, syncytium-inducing mutant strain. PS Beisser G Grauls CA Bruggeman C Vink, J Virol 1999 73 7218 7230 10438809
215. The rat cytomegalovirus R78 G protein-coupled receptor gene is required for production of infectious virus in the spleen. SJ Kaptein PS Beisser YK Gruijthuijsen KG Savelkouls KW van Cleef E Beuken GE Grauls CA Bruggeman C Vink, J Gen Virol 2003 84 2517 2530 12917474
216. The human cytomegalovirus UL78 gene is highly conserved among clinical isolates, but is dispensable for replication in fibroblasts and a renal artery organ-culture system. D Michel I Milotic M Wagner B Vaida J Holl R Ansorge T Mertens, J Gen Virol 2005 86 297 306 15659748
217. Viral chemokine-binding proteins. BT Seet G McFadden, J Leukoc Biol 2002 72 24 34 12101259
218. Secreted poxvirus chemokine binding proteins. AS Lalani G McFadden, J Leukoc Biol 1997 62 570 576 9365110
219. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. D Wang W Bresnahan T Shenk, Proc Natl Acad Sci USA 2004 101 16642 16647 15536129
220. Viruses and apoptosis. V O'Brien, J Gen Virol 1998 79 Pt 8 1833 1845 9714231
221. Cell death in development. DL Vaux SJ Korsmeyer, Cell 1999 96 245 254 9988219
222. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. ES Mocarski Jr, Trends Microbiol 2002 10 332 339 12110212
223. Control of apoptosis by human cytomegalovirus. AL McCormick, Curr Top Microbiol Immunol 2008 325 281 295 18637512
224. Cell death suppression by cytomegaloviruses. VS Goldmacher, Apoptosis 2005 10 251 265 15843887
225. vMIA, a viral inhibitor of apoptosis targeting mitochondria. VS Goldmacher, Biochimie 2002 84 177 185 12022948
226. Mitochondrial cell death suppressors carried by human and murine cytomegalovirus confer resistance to proteasome inhibitor-induced apoptosis. AL McCormick CD Meiering GB Smith ES Mocarski, J Virol 2005 79 12205 12217 16160147
227. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. VS Goldmacher LM Bartle A Skaletskaya CA Dionne NL Kedersha CA Vater JW Han RJ Lutz S Watanabe ED Cahir McFarland ED Kieff ES Mocarski T Chittenden, Proc Natl Acad Sci USA 1999 96 12536 12541 10535957
228. A cytomegalovirus-encoded inhibitor of apoptosis that suppresses caspase-8 activation. A Skaletskaya LM Bartle T Chittenden AL McCormick ES Mocarski VS Goldmacher, Proc Natl Acad Sci USA 2001 98 7829 7834 11427719
229. Human cytomegalovirus proteins encoded by UL37 exon 1 protect infected fibroblasts against virus-induced apoptosis and are required for efficient virus replication. M Reboredo RF Greaves G Hahn, J Gen Virol 2004 85 3555 3567 15557228
230. Processing of human cytomegalovirus UL37 mutant glycoproteins in the endoplasmic reticulum lumen prior to mitochondrial importation. MS Mavinakere CD Williamson VS Goldmacher AM Colberg-Poley, J Virol 2006 80 6771 6783 16809283
231. Dual targeting of the human cytomegalovirus UL37 exon 1 protein during permissive infection. MS Mavinakere AM Colberg-Poley, J Gen Virol 2004 85 323 329 14769889
232. Mitochondrial and secretory human cytomegalovirus UL37 proteins traffic into mitochondrion-associated membranes of human cells. P Bozidis CD Williamson AM Colberg-Poley, J Virol 2008 82 2715 2726 18199645
233. The sequence and antiapoptotic functional domains of the human cytomegalovirus UL37 exon 1 immediate early protein are conserved in multiple primary strains. WA Hayajneh AM Colberg-Poley A Skaletskaya LM Bartle MM Lesperance DG Contopoulos-Ioannidis NL Kedersha VS Goldmacher, Virology 2001 279 233 240 11145905
234. Human cytomegalovirus pUL37x1 induces the release of endoplasmic reticulum calcium stores. R Sharon-Friling J Goodhouse AM Colberg-Poley T Shenk, Proc Natl Acad Sci USA 2006 103 19117 19122 17135350
235. Cytomegalovirus cell death suppressor vMIA blocks Bax- but not Bak-mediated apoptosis by binding and sequestering Bax at mitochondria. D Arnoult LM Bartle A Skaletskaya D Poncet N Zamzami PU Park J Sharpe RJ Youle VS Goldmacher, Proc Natl Acad Sci USA 2004 101 7988 7993 15148411
236. An anti-apoptotic viral protein that recruits Bax to mitochondria. D Poncet N Larochette AL Pauleau P Boya AA Jalil PF Cartron F Vallette C Schnebelen LM Bartle A Skaletskaya D Boutolleau JC Martinou VS Goldmacher G Kroemer N Zamzami, J Biol Chem 2004 279 22605 22614 15004026
237. Structure-function analysis of the interaction between Bax and the cytomegalovirus-encoded protein vMIA. AL Pauleau N Larochette F Giordanetto SR Scholz D Poncet N Zamzami VS Goldmacher G Kroemer, Oncogene 2007 26 7067 7080 17496930
238. Contribution of GADD45 family members to cell death suppression by cellular Bcl-xL and cytomegalovirus vMIA. GB Smith ES Mocarski, J Virol 2005 79 14923 14932 16282491
239. HtrA2/Omi terminates cytomegalovirus infection and is controlled by the viral mitochondrial inhibitor of apoptosis (vMIA). AL McCormick L Roback ES Mocarski, PLoS Pathog 2008 4 e1000063 18769594
240. Differential function and expression of the viral inhibitor of caspase 8-induced apoptosis (vICA) and the viral mitochondria-localized inhibitor of apoptosis (vMIA) cell death suppressors conserved in primate and rodent cytomegaloviruses. AL McCormick A Skaletskaya PA Barry ES Mocarski VS Goldmacher, Virology 2003 316 221 233 14644605
241. Cytomegalovirus proteins vMIA and m38.5 link mitochondrial morphogenesis to Bcl-2 family proteins. KL Norris RJ Youle, J Virol 2008 82 13 6232 6243 18417572
242. Apoptosis-associated mitochondrial outer membrane permeabilization assays. D Arnoult, Methods 2008 44 229 234 18314053
243. Human cytomegalovirus UL36 protein is dispensable for viral replication in cultured cells. CE Patterson T Shenk, J Virol 1999 73 7126 7131 10438798
244. Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. CE Andoniou MA Degli-Esposti, Immunol Cell Biol 2006 84 99 106 16405657
245. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. M Thome P Schneider K Hofmann H Fickenscher E Meinl F Neipel C Mattmann K Burns JL Bodmer M Schroter C Scaffidi PH Krammer ME Peter J Tschopp, Nature 1997 386 517 521 9087414
246. Expression of human cytomegalovirus UL36 and UL37 genes is required for viral DNA replication. JA Smith GS Pari, J Virol 1995 69 1925 1931 7853536
247. Characterization of a cluster of late genes of guinea pig cytomegalovirus. Y Liu BJ Biegalke, Virus Genes 2001 23 247 256 11778692
248. Role of murine cytomegalovirus US22 gene family members in replication in macrophages. C Menard M Wagner Z Ruzsics K Holak W Brune AE Campbell UH Koszinowski, J Virol 2003 77 5557 5570 12719548
249. Dominant-negative FADD rescues the in vivo fitness of a cytomegalovirus lacking an antiapoptotic viral gene. L Cicin-Sain Z Ruzsics J Podlech I Bubic C Menard S Jonjic MJ Reddehase UH Koszinowski, J Virol 2008 82 2056 2064 18094168
250. Expression of an altered ribonucleotide reductase activity associated with the replication of murine cytomegalovirus in quiescent fibroblasts. D Lembo G Gribaudo A Hofer L Riera M Cornaglia A Mondo A Angeretti M Gariglio L Thelander S Landolfo, J Virol 2000 74 11557 11565 11090153
251. The ribonucleotide reductase R1 homolog of murine cytomegalovirus is not a functional enzyme subunit but is required for pathogenesis. D Lembo M Donalisio A Hofer M Cornaglia W Brune U Koszinowski L Thelander S Landolfo, J Virol 2004 78 4278 4288 15047841
252. A ribonucleotide reductase homolog of cytomegalovirus and endothelial cell tropism. W Brune C Menard J Heesemann UH Koszinowski, Science 2001 291 303 305 11209080
253. Cytomegalovirus M45 cell death suppression requires RHIM-dependent interaction with receptor-interacting protein 1 (RIP1). JW Upton WJ Kaiser ES Mocarski, J Biol Chem 2008 18442983
254. Inhibition of proinflammatory and innate immune signaling pathways by a cytomegalovirus RIP1-interacting protein. C Mack A Sickmann D Lembo W Brune, Proc Natl Acad Sci USA 2008 105 3094 3099 18287053
255. Fas triggers an alternative, caspase-8-independent cell death pathway using the kinase RIP as effector molecule. N Holler R Zaru O Micheau M Thome A Attinger S Valitutti JL Bodmer P Schneider B Seed J Tschopp, Nat Immunol 2000 1 489 495 11101870
256. Herpesvirus interference with major histocompatibility complex class II-restricted T-cell activation. EJ Wiertz R Devlin HL Collins ME Ressing, J Virol 2007 81 4389 4396 17079308
257. Viral mechanisms of immune evasion. A Alcami UH Koszinowski, Trends Microbiol 2000 8 410 418 10989308
258. Cytomegaloviral control of MHC class I function in the mouse. H Hengel U Reusch A Gutermann H Ziegler S Jonjic P Lucin UH Koszinowski, Immunol Rev 1999 168 167 176 10399073
259. Herpesvirus-specific CD8 T cell immunity in old age: cytomegalovirus impairs the response to a coresident EBV infection. N Khan A Hislop N Gudgeon M Cobbold R Khanna L Nayak AB Rickinson PA Moss, J Immunol 2004 173 7481 7489 15585874
260. Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - an impact of immunosenescence. P Trzonkowski J Mysliwska E Szmit J Wieckiewicz K Lukaszuk LB Brydak M Machala A Mysliwski, Vaccine 2003 21 3826 3836 12922116
261. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. TR Jones LK Hanson L Sun JS Slater RM Stenberg AE Campbell, J Virol 1995 69 4830 4841 7609050
262. Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex class I molecules into the medial-Golgi compartment. M del Val H Hengel H Hacker U Hartlaub T Ruppert P Lucin UH Koszinowski, J Exp Med 1992 176 729 738 1324970
263. Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination. AR Thrower GC Bullock JE Bissell MF Stinski, J Virol 1996 70 91 100 8523597
264. Expression dynamics of human cytomegalovirus immune evasion genes US3, US6, and US11 in the blood of lung transplant recipients. AE Greijer EA Verschuuren CA Dekkers HM Adriaanse W van der Bij TH The JM Middeldorp, J Infect Dis 2001 184 247 255 11443549
265. Human cytomegalovirus US3 impairs transport and maturation of major histocompatibility complex class I heavy chains. TR Jones EJ Wiertz L Sun KN Fish JA Nelson HL Ploegh, Proc Natl Acad Sci USA 1996 93 11327 11333 8876135
266. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. K Ahn A Angulo P Ghazal PA Peterson Y Yang K Fruh, Proc Natl Acad Sci USA 1996 93 10990 10995 8855296
267. Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. Y Jun E Kim M Jin HC Sung H Han DE Geraghty K Ahn, J Immunol 2000 164 805 811 10623826
268. Human cytomegalovirus immediate early glycoprotein US3 retains MHC class I molecules by transient association. A Gruhler PA Peterson K Fruh, Traffic 2000 1 318 325 11208117
269. Inhibition of HLA-DR assembly, transport, and loading by human cytomegalovirus glycoprotein US3: a novel mechanism for evading major histocompatibility complex class II antigen presentation. NR Hegde RA Tomazin TW Wisner C Dunn JM Boname DM Lewinsohn DC Johnson, J Virol 2002 76 10929 10941 12368336
270. Structural and functional dissection of human cytomegalovirus US3 in binding major histocompatibility complex class I molecules. S Lee J Yoon B Park Y Jun M Jin HC Sung IH Kim S Kang EJ Choi BY Ahn K Ahn, J Virol 2000 74 11262 11269 11070025
271. Functional analysis of the human cytomegalovirus immune evasion protein, pUS3(22kDa). Y Zhao BJ Biegalke, Virology 2003 315 353 361 14585338
272. Determinant for endoplasmic reticulum retention in the luminal domain of the human cytomegalovirus US3 glycoprotein. S Lee B Park K Ahn, J Virol 2003 77 2147 2156 12525649
273. Structural and functional analysis of human cytomegalovirus US3 protein. S Misaghi ZY Sun P Stern R Gaudet G Wagner H Ploegh, J Virol 2004 78 413 423 14671122
274. Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. B Park Y Kim J Shin S Lee K Cho K Fruh K Ahn, Immunity 2004 20 71 85 14738766
275. A short isoform of human cytomegalovirus US3 functions as a dominant negative inhibitor of the full-length form. J Shin B Park S Lee Y Kim BJ Biegalke S Kang K Ahn, J Virol 2006 80 5397 5404 16699020
276. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction. EJ Wiertz D Tortorella M Bogyo J Yu W Mothes TR Jones TA Rapoport HL Ploegh, Nature 1996 384 432 438 8945469
277. The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. EJ Wiertz TR Jones L Sun M Bogyo HJ Geuze HL Ploegh, Cell 1996 84 769 779 8625414
278. Human cytomegalovirus US2 destabilizes major histocompatibility complex class I heavy chains. TR Jones L Sun, J Virol 1997 71 2970 2979 9060656
279. Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells. A Rehm A Engelsberg D Tortorella IJ Korner I Lehmann HL Ploegh UE Hopken, J Virol 2002 76 5043 5050 11967320
280. Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol. M Kikkert G Hassink M Barel C Hirsch FJ van der Wal E Wiertz, Biochem J 2001 358 369 377 11513735
281. Ubiquitination of MHC class I heavy chains is essential for dislocation by human cytomegalovirus-encoded US2 but not US11. GC Hassink MT Barel SB Van Voorden M Kikkert EJ Wiertz, J Biol Chem 2006 281 30063 30071 16877758
282. The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. CE Shamu CM Story TA Rapoport HL Ploegh, J Cell Biol 1999 147 45 58 10508854
283. E2-25K mediates US11-triggered retro-translocation of MHC class I heavy chains in a permeabilized cell system. D Flierman CS Coleman CM Pickart TA Rapoport V Chau, Proc Natl Acad Sci USA 2006 103 11589 11594 16868077
284. Polyubiquitination is required for US11-dependent movement of MHC class I heavy chain from endoplasmic reticulum into cytosol. CE Shamu D Flierman HL Ploegh TA Rapoport V Chau, Mol Biol Cell 2001 12 2546 2555 11514634
285. Human cytomegalovirus protein US11 provokes an unfolded protein response that may facilitate the degradation of class I major histocompatibility complex products. B Tirosh NN Iwakoshi BN Lilley AH Lee LH Glimcher HL Ploegh, J Virol 2005 79 2768 2779 15708995
286. Binding of human cytomegalovirus US2 to major histocompatibility complex class I and II proteins is not sufficient for their degradation. MS Chevalier GM Daniels DC Johnson, J Virol 2002 76 8265 8275 12134032
287. Human cytomegalovirus-encoded US2 and US11 target unassembled MHC class I heavy chains for degradation. MT Barel GC Hassink S van Voorden EJ Wiertz, Mol Immunol 2006 43 1258 1266 16098592
288. Endoplasmic reticulum chaperones participate in human cytomegalovirus US2-mediated degradation of class I major histocompatibility complex molecules. K Oresic D Tortorella, J Gen Virol 2008 89 1122 1130 18420789
289. A membrane protein required for dislocation of misfolded proteins from the ER. BN Lilley HL Ploegh, Nature 2004 429 834 840 15215855
290. Human cytomegalovirus-encoded US2 differentially affects surface expression of MHC class I locus products and targets membrane-bound, but not soluble HLA-G1 for degradation. MT Barel M Ressing N Pizzato D van Leeuwen P Le Bouteiller F Lenfant EJ Wiertz, J Immunol 2003 171 6757 6765 14662880
291. Trophoblast class I major histocompatibility complex (MHC) products are resistant to rapid degradation imposed by the human cytomegalovirus (HCMV) gene products US2 and US11. DJ Schust D Tortorella J Seebach C Phan HL Ploegh, J Exp Med 1998 188 497 503 9687527
292. The HCMV gene products US11 and US2 differ in their ability to attack allelic forms of murine major histocompatibility complex (MHC) class I heavy chains. RP Machold EJ Wiertz TR Jones HL Ploegh, J Exp Med 1997 185 363 366 9016885
293. Membrane-specific, host-derived factors are required for US2- and US11-mediated degradation of major histocompatibility complex class I molecules. MH Furman HL Ploegh D Tortorella, J Biol Chem 2002 277 3258 3267 11717308
294. Antigen presentation subverted: Structure of the human cytomegalovirus protein US2 bound to the class I molecule HLA-A2. BE Gewurz R Gaudet D Tortorella EW Wang HL Ploegh DC Wiley, Proc Natl Acad Sci USA 2001 98 6794 6799 11391001
295. Human cytomegalovirus US2 endoplasmic reticulum-lumenal domain dictates association with major histocompatibility complex class I in a locus-specific manner. BE Gewurz EW Wang D Tortorella DJ Schust HL Ploegh, J Virol 2001 75 5197 5204 11333901
296. The cytosolic tail of class I MHC heavy chain is required for its dislocation by the human cytomegalovirus US2 and US11 gene products. CM Story MH Furman HL Ploegh, Proc Natl Acad Sci USA 1999 96 8516 8521 10411907
297. Dissection of the interaction of the human cytomegalovirus-derived US2 protein with major histocompatibility complex class I molecules: prominent role of a single arginine residue in human leukocyte antigen-A2. C Thilo P Berglund SE Applequist JW Yewdell HG Ljunggren A Achour, J Biol Chem 2006 281 8950 8957 16452487
298. Amino acid composition of alpha1/alpha2 domains and cytoplasmic tail of MHC class I molecules determine their susceptibility to human cytomegalovirus US11-mediated down-regulation. MT Barel N Pizzato D van Leeuwen PL Bouteiller EJ Wiertz F Lenfant, Eur J Immunol 2003 33 1707 1716 12778489
299. Functional dissection of HCMV US11 in mediating the degradation of MHC class I molecules. SO Lee S Hwang J Park B Park BS Jin S Lee E Kim S Cho Y Kim K Cho J Shin K Ahn, Biochem Biophys Res Commun 2005 330 1262 1267 15823579
300. A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. H Hengel JO Koopmann T Flohr W Muranyi E Goulmy GJ Hammerling UH Koszinowski F Momburg, Immunity 1997 6 623 632 9175840
301. The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. K Ahn A Gruhler B Galocha TR Jones EJ Wiertz HL Ploegh PA Peterson Y Yang K Fruh, Immunity 1997 6 613 621 9175839
302. The major immediate-early proteins IE1 and IE2 of human cytomegalovirus colocalize with and disrupt PML-associated nuclear bodies at very early times in infected permissive cells. JH Ahn GS Hayward, J Virol 1997 71 4599 4613 9151854
303. Physical and functional interactions of the cytomegalovirus US6 glycoprotein with the transporter associated with antigen processing. A Halenius F Momburg H Reinhard D Bauer M Lobigs H Hengel, J Biol Chem 2006 281 5383 5390 16356928
304. Molecular mechanism and structural aspects of transporter associated with antigen processing inhibition by the cytomegalovirus protein US6. C Kyritsis S Gorbulev S Hutschenreiter K Pawlitschko R Abele R Tampe, J Biol Chem 2001 276 48031 48039 11606590
305. Structural and Functional Dissection of the Human Cytomegalovirus Immune Evasion Protein US6. GE Dugan EW Hewitt, J Virol 2008 82 3271 3282 18199642
306. The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EW Hewitt SS Gupta PJ Lehner, EMBO J 2001 20 387 396 11157746
307. Human cytomegalovirus inhibits peptide translocation into the endoplasmic reticulum for MHC class I assembly. H Hengel T Flohr GJ Hammerling UH Koszinowski F Momburg, J Gen Virol 1996 77 Pt 9 2287 2296 8811029
308. Differential effects of US2, US6 and US11 human cytomegalovirus proteins on HLA class Ia and HLA-E expression: impact on target susceptibility to NK cell subsets. M Llano M Guma M Ortega A Angulo M Lopez-Botet, Eur J Immunol 2003 33 2744 2754 14515258
309. The human cytomegalovirus US8 glycoprotein binds to major histocompatibility complex class I products. RS Tirabassi HL Ploegh, J Virol 2002 76 6832 6835 12050396
310. The human cytomegalovirus US10 gene product delays trafficking of major histocompatibility complex class I molecules. MH Furman N Dey D Tortorella HL Ploegh, J Virol 2002 76 11753 11756 12388737
311. Complete sequence and genomic analysis of rhesus cytomegalovirus. SG Hansen LI Strelow DC Franchi DG Anders SW Wong, J Virol 2003 77 6620 6636 12767982
312. Rhesus cytomegalovirus contains functional homologues of US2, US3, US6, and US11. NT Pande C Powers K Ahn K Fruh, J Virol 2005 79 5786 5798 15827193
313. Signal peptide-dependent inhibition of MHC class I heavy chain translation by rhesus cytomegalovirus. CJ Powers K Fruh, PLoS Pathog 2008 4 e1000150 18833297
314. A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. H Ziegler R Thale P Lucin W Muranyi T Flohr H Hengel H Farrell W Rawlinson UH Koszinowski, Immunity 1997 6 57 66 9052837
315. A cytomegalovirus glycoprotein re-routes MHC class I complexes to lysosomes for degradation. U Reusch W Muranyi P Lucin HG Burgert H Hengel UH Koszinowski, EMBO J 1999 18 1081 1091 10022849
316. The immunoevasive function encoded by the mouse cytomegalovirus gene m152 protects the virus against T cell control in vivo. A Krmpotic M Messerle I Crnkovic-Mertens B Polic S Jonjic UH Koszinowski, J Exp Med 1999 190 1285 1296 10544200
317. Cytomegalovirus encodes a positive regulator of antigen presentation. R Holtappels D Gillert-Marien D Thomas J Podlech P Deegen S Herter SA Oehrlein-Karpi D Strand M Wagner MJ Reddehase, J Virol 2006 80 7613 7624 16840340
318. The multiple immune-evasion genes of murine cytomegalovirus are not redundant: m4 and m152 inhibit antigen presentation in a complementary and cooperative fashion. DG Kavanagh MC Gold M Wagner UH Koszinowski AB Hill, J Exp Med 2001 194 967 978 11581318
319. Major histocompatibility complex class I allele-specific cooperative and competitive interactions between immune evasion proteins of cytomegalovirus. M Wagner A Gutermann J Podlech MJ Reddehase UH Koszinowski, J Exp Med 2002 196 805 816 12235213
320. Effective inhibition of K(b)- and D(b)-restricted antigen presentation in primary macrophages by murine cytomegalovirus. DM LoPiccolo MC Gold DG Kavanagh M Wagner UH Koszinowski AB Hill, J Virol 2003 77 301 308 12477835
321. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus. H Hengel U Reusch G Geginat R Holtappels T Ruppert E Hellebrand UH Koszinowski, J Virol 2000 74 7861 7868 10933693
322. The murine cytomegalovirus immunomodulatory gene m152 prevents recognition of infected cells by M45-specific CTL but does not alter the immunodominance of the M45-specific CD8 T cell response in vivo. MC Gold MW Munks M Wagner UH Koszinowski AB Hill SP Fling, J Immunol 2002 169 359 365 12077265
323. Coordinated function of murine cytomegalovirus genes completely inhibits CTL lysis. AK Pinto MW Munks UH Koszinowski AB Hill, J Immunol 2006 177 3225 3234 16920962
324. Viral interference with antigen presentation does not alter acute or chronic CD8 T cell immunodominance in murine cytomegalovirus infection. MW Munks AK Pinto CM Doom AB Hill, J Immunol 2007 178 7235 7241 17513772
325. Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy. V Bohm J Podlech D Thomas P Deegen MF Pahl-Seibert NA Lemmermann NK Grzimek SA Oehrlein-Karpi MJ Reddehase R Holtappels, Med Microbiol Immunol 2008 197 135 144 18340461
326. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but is transported to the cell surface. MF Kleijnen JB Huppa P Lucin S Mukherjee H Farrell AE Campbell UH Koszinowski AB Hill HL Ploegh, EMBO J 1997 16 685 694 9049298
327. Cellular and molecular requirements for association of the murine cytomegalovirus protein m4/gp34 with major histocompatibility complex class I molecules. X Lu DG Kavanagh AB Hill, J Virol 2006 80 6048 6055 16731943
328. Reduced expression of HLA class II molecules and Iinterleukin-10- and transforming growth factor beta1-independent suppression of T-cell proliferation in human cytomegalovirus-infected macrophage cultures. J Odeberg C Soderberg-Naucler, J Virol 2001 75 5174 5181 11333898
329. Cytomegalovirus US2 destroys two components of the MHC class II pathway, preventing recognition by CD4+ T cells. R Tomazin J Boname NR Hegde DM Lewinsohn Y Altschuler TR Jones P Cresswell JA Nelson SR Riddell DC Johnson, Nat Med 1999 5 1039 1043 10470081
330. Human cytomegalovirus US2 causes similar effects on both major histocompatibility complex class I and II proteins in epithelial and glial cells. NR Hegde DC Johnson, J Virol 2003 77 9287 9294 12915544
331. Human cytomegalovirus US3 chimeras containing US2 cytosolic residues acquire major histocompatibility class I and II protein degradation properties. MS Chevalier DC Johnson, J Virol 2003 77 4731 4738 12663780
332. Human cytomegalovirus protein pp65 mediates accumulation of HLA-DR in lysosomes and destruction of the HLA-DR alpha-chain. J Odeberg B Plachter L Branden C Soderberg-Naucler, Blood 2003 101 4870 4877 12609847
333. Murine cytomegalovirus inhibits interferon gamma-induced antigen presentation to CD4 T cells by macrophages via regulation of expression of major histocompatibility complex class II-associated genes. MT Heise M Connick HWt Virgin, J Exp Med 1998 187 1037 1046 9529320